{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:59:04Z","timestamp":1789883944135,"version":"4.0.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/olq.0b013e318063c749","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T04:02:02Z","timestamp":1181016122000},"page":"900-907","source":"Crossref","is-referenced-by-count":30,"title":["Famciclovir Reduces Viral Mucosal Shedding in HSV-Seropositive Persons"],"prefix":"10.1097","volume":"34","author":[{"given":"Peter","family":"Leone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Fife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210213","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.","volume":"296","author":"Xu","year":"2006","journal-title":"JAMA"},{"issue":"Suppl 3","key":"R2-14-20210213","first-page":"130A","article-title":"Herpes simplex virus type 2 transmission: risk factors and virus shedding.","volume":"11","author":"Wald","year":"2004","journal-title":"Herpes"},{"key":"R3-14-20210213","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-116-6-433","article-title":"Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes.","volume":"116","author":"Koelle","year":"1992","journal-title":"Ann Intern Med"},{"key":"R4-14-20210213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00007435-198501000-00007","article-title":"Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts.","volume":"b12","author":"Mertz","year":"1985","journal-title":"Sex Transm Dis"},{"key":"R5-14-20210213","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM199509213331205","article-title":"Virologic characteristics of subclinical and symptomatic genital herpes infections.","volume":"333","author":"Wald","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-14-20210213","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJM200003233421203","article-title":"Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.","volume":"342","author":"Wald","year":"2000","journal-title":"N Engl J Med"},{"key":"R7-14-20210213","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/504717","article-title":"Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition.","volume":"194","author":"Wald","year":"2006","journal-title":"J Infect Dis"},{"key":"R8-14-20210213","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.olq.0000151414.64297.46","article-title":"Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women.","volume":"32","author":"Cherpes","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R9-14-20210213","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1086\/315395","article-title":"Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.","volume":"181","author":"Lafferty","year":"2000","journal-title":"J Infect Dis"},{"key":"R10-14-20210213","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.OLQ.0000092387.58746.C7","article-title":"Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.","volume":"30","author":"Roberts","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R11-14-20210213","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/424519","article-title":"Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.","volume":"190","author":"Gupta","year":"2004","journal-title":"J Infect Dis"},{"key":"R12-14-20210213","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00002","article-title":"Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.","volume":"124","author":"Wald","year":"1996","journal-title":"Ann Intern Med"},{"key":"R13-14-20210213","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.olq.0000204723.15765.91","article-title":"Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.","volume":"33","author":"Wald","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R14-14-20210213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa035144","article-title":"Once-daily valacyclovir to reduce the risk of transmission of genital herpes.","volume":"350","author":"Corey","year":"2004","journal-title":"N Engl J Med"},{"key":"R15-14-20210213","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.36.12.2747","article-title":"Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.","volume":"36","author":"Earnshaw","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-14-20210213","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/AAC.33.10.1765","article-title":"Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir].","volume":"33","author":"Vere Hodge","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-14-20210213","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/JCM.26.4.662-667.1988","article-title":"Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.","volume":"26","author":"Ashley","year":"1988","journal-title":"J Clin Microbiol"},{"key":"R18-14-20210213","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI111260","article-title":"Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.","volume":"73","author":"Ashley","year":"1984","journal-title":"J Clin Invest"},{"key":"R19-14-20210213","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jmv.20365","article-title":"Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay.","volume":"76","author":"Corey","year":"2005","journal-title":"J Med Virol"},{"key":"R20-14-20210213","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1128\/JCM.40.7.2609-2611.2002","article-title":"Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR.","volume":"40","author":"Jerome","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R21-14-20210213","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/383038","article-title":"Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial.","volume":"189","author":"Sacks","year":"2004","journal-title":"J Infect Dis"},{"key":"R22-14-20210213","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/500841","article-title":"The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic.","volume":"193","author":"Sizemore","year":"2006","journal-title":"J Infect Dis"},{"key":"R23-14-20210213","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1086\/505879","article-title":"Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.","volume":"194","author":"Kim","year":"2006","journal-title":"J Infect Dis"},{"key":"R24-14-20210213","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/sti.2003.007823","article-title":"Oral shedding of herpes simplex virus type 2.","volume":"80","author":"Wald","year":"2004","journal-title":"Sex Transm Infect"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-200711000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:42:34Z","timestamp":1786034554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-200711000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e318063c749","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}